NCT07370857

Brief Summary

This study was designed to investigate the effects of music medicine on anxiety, pain, and vital signs in women undergoing embryo transfer. The study followed a randomized controlled design and was conducted at the IVF unit of a university hospital. The sample consisted of women who met the specified inclusion criteria, and participants were assigned to the intervention and control groups using randomization. Data collection tools included a socio-demographic characteristics form, a vital signs recording form (blood pressure, pulse, respiratory rate, and oxygen saturation), the State-Trait Anxiety Inventory (STAI-I and II), and the Visual Analogue Scale (VAS). The intervention group listened to patient-selected music during the embryo transfer process, while the control group received standard care. Measurements were taken before, during, and after the embryo transfer. The obtained data were analyzed using appropriate statistical methods to evaluate the effects of music on anxiety, pain levels, and vital signs. This study aims to improve women's embryo transfer experiences by contributing to nursing care and reproductive health practices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 17, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 17, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 27, 2026

Completed
Last Updated

January 27, 2026

Status Verified

May 1, 2025

Enrollment Period

5 months

First QC Date

December 17, 2025

Last Update Submit

January 20, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • State Anxiety Score

    Measured using the Spielberger State-Trait Anxiety Inventory (STAI). Only the "State" subscale is used to assess the current level of anxiety related to the embryo transfer procedure. The score ranges from 20 to 80, where higher scores indicate higher levels of anxiety.

    Measured at two time points: baseline (pre-test, upon admission to the room) and 15 minutes after the embryo transfer procedure (post-test).

Study Arms (2)

Music Medicine Group

EXPERIMENTAL

Patients in this group receive music medicine intervention in addition to standard care during the embryo transfer process.

Behavioral: "Patient-Selected Music Medicine

Control Group

NO INTERVENTION

Participants receive only the standard clinical procedures and routine care for embryo transfer without any music intervention.

Interventions

Participants in the intervention group listen to their pre-selected music through high-quality, over-ear active noise-canceling headphones to ensure acoustic isolation. The music intervention begins immediately before the embryo transfer, continues throughout the procedure, and extends for 15 minutes in the recovery room. The volume is adjusted by the patient to a comfortable level, and disposable covers are used on the headphones for hygiene.

Music Medicine Group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women undergoing embryo transfer.
  • Ages 18 to 45 years (or your specific age range).
  • Literacy in Turkish to complete the inventories.
  • Voluntarily agreeing to participate in the study.

You may not qualify if:

  • Patients with hearing impairment.
  • Patients with cognitive or psychiatric disorders that prevent completion of the inventory.
  • Patients who have taken analgesic or anxiolytic medication within the last 24 hours.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Harran University

Sanliurfa, Şanlıurfa, 63000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

AgnosiaInfertilityAnxiety Disorders

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsGenital DiseasesUrogenital DiseasesMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Randomization was performed using the sealed envelope method to ensure allocation concealment; therefore, the investigator did not know the group assignments until the point of intervention. Due to the nature of the music medicine intervention, the participants and the investigator collecting the data could not be masked during the procedure. However, to minimize bias, the statistical analysis will be conducted by a researcher blinded to the group allocations.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: 1. Music Medicine Group (Arm 1) Label: Music Medicine Group Arm Type: Experimental Description: Participants listen to patient-selected music via noise-canceling headphones throughout the embryo transfer procedure and for 15 minutes post-procedure, in addition to standard care. 2. Control Group (Arm 2) Label: Control Group Arm Type: No Intervention Description: Participants receive standard clinical care for the embryo transfer procedure without any music medicine intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Candidate

Study Record Dates

First Submitted

December 17, 2025

First Posted

January 27, 2026

Study Start

May 1, 2025

Primary Completion

October 1, 2025

Study Completion

December 17, 2025

Last Updated

January 27, 2026

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared to protect participant privacy and because the data are currently being used as part of a doctoral dissertation. Results will be disseminated through publication in peer-reviewed journals.

Locations